Publicaciones en las que colabora con Javier Segovia Cubero (61)

2020

  1. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367

  2. Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323

  3. Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 207-216

2019

  1. Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

    Clinical Therapeutics, Vol. 41, Núm. 1, pp. 130-136

  2. Prognostic Value of Serum Lactate Levels in Patients Undergoing Urgent Heart Transplant: A Subanalysis of the ASIS-TC Spanish Multicenter Study

    Revista Espanola de Cardiologia, Vol. 72, Núm. 3, pp. 208-214

  3. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

  4. Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 954-962

  5. Use of Intra-aortic Balloon Pump as a Bridge to Heart Transplant in Spain: Results From the ASIS-TC Study

    Revista Espanola de Cardiologia, Vol. 72, Núm. 10, pp. 835-843

2018

  1. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

    Journal of the American College of Cardiology, Vol. 72, Núm. 20, pp. 2471-2481

  2. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study

    American Journal of Transplantation, Vol. 18, Núm. 6, pp. 1447-1460

  3. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

  4. Practice patterns to improve pre and post-transplant medication adherence in heart transplant centres: a secondary data analysis of the international BRIGHT study

    European Journal of Cardiovascular Nursing, Vol. 17, Núm. 4, pp. 356-367

  5. Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 71, Núm. 8, pp. 612-619

  6. Selection of the Best of 2017 in Acute and Chronic Heart Failure

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 298-299

  7. Selection of the Best of 2017 in Cardiac Transplant and Ventricular Assist Devices

    Revista Espanola de Cardiologia, Vol. 71, Núm. 4, pp. 300-301

  8. The international prevalence and variability of nonadherence to the nonpharmacologic treatment regimen after heart transplantation: Findings from the cross-sectional BRIGHT study

    Clinical Transplantation, Vol. 32, Núm. 7

2017

  1. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study

    Journal of Heart and Lung Transplantation, Vol. 36, Núm. 5, pp. 529-539

  2. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management – Findings from the International BRIGHT Study

    Heart and Lung, Vol. 46, Núm. 5, pp. 351-356

2016

  1. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 18, Núm. 7, pp. 859-868

  2. Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 35, Núm. 5, pp. 625-635